We are live on ! Find out more
APM

Avidity Partners Management Portfolio holdings

AUM $624M Turnover 44.83%
1-Year Est. Return 250.2%
This Fund
S&P 500
This Quarter Est. Return
+45.78%
1 Year Est. Return
+250.2%
3 Year Est. Return
+491.63%
5 Year Est. Return
+985.37%
10 Year Est. Return
–
AUM
$159M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow %
86.65%
Top 10 Hldgs %
52.06%
Holding
33
New
33
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$13.7M
2
HCA icon
HCA Healthcare
HCA
+$8.42M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.1M
4
ABBV icon
AbbVie
ABBV
+$7.8M
5
ZBH icon
Zimmer Biomet
ZBH
+$7.75M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BAX icon
1
Baxter International
BAX
$13.3B
$13.8M 8.69%
+165,000
New +$13.7M
2019 Q4
0 quarters
HCA icon
2
HCA Healthcare
HCA
$101B
$9.27M 5.84%
+62,700
New +$8.42M
2019 Q4
0 quarters
VRTX icon
3
Vertex Pharmaceuticals
VRTX
$129B
$8.76M 5.52%
+40,000
New +$8.1M
2019 Q4
0 quarters
ABBV icon
4
AbbVie
ABBV
$501B
$8.32M 5.24%
+94,000
New +$7.8M
2019 Q4
0 quarters
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.25M 5.2%
+64,000
New +$6.17M
2019 Q4
0 quarters
ZBH icon
6
Zimmer Biomet
ZBH
$18B
$8.16M 5.14%
+56,135
New +$7.75M
2019 Q4
0 quarters
ESPR icon
7
DELISTED
Esperion Therapeutics
ESPR
$7.78M 4.9%
+130,400
New +$5.86M
2019 Q4
0 quarters
EW icon
8
Edwards Lifesciences
EW
$50.8B
$6.3M 3.97%
+81,000
New +$6.32M
2019 Q4
0 quarters
CI icon
9
Cigna
CI
$79B
$6.13M 3.87%
+30,000
New +$5.5M
2019 Q4
0 quarters
ASND icon
10
Ascendis Pharma A/S
ASND
$14.9B
$5.86M 3.69%
+42,100
New +$4.68M
2019 Q4
0 quarters
AXNX icon
11
DELISTED
Axonics, Inc. Common Stock
AXNX
$5.76M 3.63%
+208,000
New +$4.96M
2019 Q4
0 quarters
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.43M 3.42%
+150,000
New +$4.6M
2019 Q4
0 quarters
NXTC icon
13
NextCure
NXTC
$31.5M
$5.24M 3.3%
+7,750
New +$3.89M
2019 Q4
0 quarters
CTLT icon
14
DELISTED
CATALENT, INC.
CTLT
$5.18M 3.26%
+92,000
New +$4.69M
2019 Q4
0 quarters
AUPH icon
15
Aurinia Pharmaceuticals
AUPH
$2.23B
$4.7M 2.96%
+232,000
New +$2.14M
2019 Q4
0 quarters
DVAX icon
16
DELISTED
Dynavax Technologies
DVAX
$4.46M 2.81%
+780,000
New +$4.17M
2019 Q4
0 quarters
ABEO icon
17
Abeona Therapeutics
ABEO
$266M
$4.33M 2.73%
+53,000
New +$3.74M
2019 Q4
0 quarters
DXCM icon
18
DexCom
DXCM
$33.1B
$4.16M 2.62%
+76,000
New +$3.6M
2019 Q4
0 quarters
MNTA
19
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$3.95M 2.49%
+200,000
New +$3.2M
2019 Q4
0 quarters
QURE icon
20
uniQure
QURE
$1.56B
$3.94M 2.48%
+55,000
New +$3.02M
2019 Q4
0 quarters
CHRS icon
21
Coherus Oncology
CHRS
$165M
$3.86M 2.43%
+214,500
New +$3.96M
2019 Q4
0 quarters
KDMN
22
DELISTED
Kadmon Holdings, Inc.
KDMN
$3.76M 2.37%
+830,000
New +$3.04M
2019 Q4
0 quarters
COLL icon
23
Collegium Pharmaceutical
COLL
$755M
$3.7M 2.33%
+180,000
New +$3M
2019 Q4
0 quarters
NBIX icon
24
Neurocrine Biosciences
NBIX
$13.9B
$3.55M 2.24%
+33,000
New +$3.46M
2019 Q4
0 quarters
IMMU
25
DELISTED
Immunomedics Inc
IMMU
$2.96M 1.87%
+140,000
New +$2.47M
2019 Q4
0 quarters
1
2

Similar funds

ANB
Amarillo National Bank Amarillo, Texas $624M AUM 20.28% 1-Year Est. Return
CWM
Chemistry Wealth Management New York $625M AUM 19.32% 1-Year Est. Return
RIP
RAM Investment Partners Bellevue, Washington $625M AUM 16.29% 1-Year Est. Return
TAM
Third Avenue Management New York $625M AUM 48.93% 1-Year Est. Return
B
Bellecapital Zurich, Switzerland $625M AUM 39.69% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $623M AUM 30.7% 1-Year Est. Return
LWP
LMG Wealth Partners Shreveport, Louisiana $626M AUM 36.27% 1-Year Est. Return
TAA
TB Alternative Assets Grand Cayman, Cayman Islands $623M AUM 154.99% 1-Year Est. Return

Avidity Partners Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Avidity Partners Management, which disclosed 33 positions worth $159M. Its ten largest holdings account for 52% of the portfolio.

Its largest position is Baxter International: 165,000 shares worth $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Avidity Partners Management's largest Q4 2019 buy was Baxter International: 165,000 shares worth $13.8M.
  • Avidity Partners Management's ten largest holdings make up 52% of its $159M portfolio in Q4 2019.
  • Avidity Partners Management disclosed 33 positions in Q4 2019, its first 13F filing on record.

Based on Avidity Partners Management's 13F filing for Q4 2019, filed 14 Feb 2020.